Cargando…
Bladder Cancer Immunotherapy by BCG Is Associated with a Significantly Reduced Risk of Alzheimer’s Disease and Parkinson’s Disease
Bacillus Calmette–Guerin (BCG) is a live attenuated form of Mycobacterium bovis that was developed 100 years ago as a vaccine against tuberculosis (TB) and has been used ever since to vaccinate children globally. It has also been used as the first-line treatment in patients with nonmuscle invasive b...
Autores principales: | Klinger, Danielle, Hill, Brian L., Barda, Noam, Halperin, Eran, Gofrit, Ofer N., Greenblatt, Charles L., Rappoport, Nadav, Linial, Michal, Bercovier, Hervé |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151667/ https://www.ncbi.nlm.nih.gov/pubmed/34064775 http://dx.doi.org/10.3390/vaccines9050491 |
Ejemplares similares
-
Bacillus Calmette-Guérin (BCG) therapy lowers the incidence of Alzheimer’s disease in bladder cancer patients
por: Gofrit, Ofer N., et al.
Publicado: (2019) -
Significantly Improved COVID-19 Outcomes in Countries with Higher BCG Vaccination Coverage: A Multivariable Analysis
por: Klinger, Danielle, et al.
Publicado: (2020) -
Bacillus Calmette–Guérin in Immuno-Regulation of Alzheimer’s Disease
por: Klein, Benjamin Y., et al.
Publicado: (2022) -
Overlooked Short Toxin-Like Proteins: A Shortcut to Drug Design
por: Linial, Michal, et al.
Publicado: (2017) -
ProteinBERT: a universal deep-learning model of protein sequence and function
por: Brandes, Nadav, et al.
Publicado: (2022)